| 指标 | Hp阳性n(%) | Hp阴性n(%) | χ2值 | P值 | |
| 年龄(岁) |
|
|
|
| |
| <60 | 19 (42.2) | 14 (42.4) | 0.000 | 0.986 | |
| ≥60 | 26 (57.8) | 19 (57.6) | |||
| 性别 |
|
|
|
| |
| 男 | 32 (71.1) | 26 (78.8) | 0.588 | 0.601 | |
| 女 | 13 (28.9) | 7 (21.2) | |||
| 淋巴结转移 |
|
|
|
| |
| 无 | 27 (60.0) | 17 (51.5) | 0.557 | 0.455 | |
| 有 | 18 (40.0) | 16 (46.5) | |||
| 胃腺癌分化程度 |
|
|
|
| |
| 高分化 | 1 (2.8) | 1 (3.6) |
|
| |
| 中分化 | 21 (58.3) | 12 (42.9) | 1.754 | 0.479 | |
| 低分化 | 14 (38.9) | 15 (53.6) |
|
| |
| 浸润深度 |
|
|
|
| |
| 黏膜层 | 8 (24.2) | 4 (8.9) |
|
| |
| 黏膜下层 | 17 (51.5) | 14 (31.1) | 0.781 | 0.854 | |
| 肌层 | 13 (39.4) | 11 (24.4) | |||
| 浆膜层 | 7 (21.2) | 4 (8.9) |
|
| |
| 临床分期 |
|
|
|
| |
| I期 | 12 (26.7) | 12 (36.4) |
|
| |
| II期 | 18 (40.0) | 8 (24.2) | 2.647 | 0.453 | |
| III期 | 11 (24.4) | 8 (24.2) | |||
| IV期 | 4 (8.9) | 5 (15.2) |
|
| |